Brown Gibbons Lang & Company (BGL) has announced the sale of United States Drug Testing Laboratories to Northlane Capital Partners (NCP), a private equity firm specialising in healthcare and business services.
Molex, a parent to Phillips Medisize, announced that it has completed, through an affiliate, the previously announced acquisition of Vectura Group from Vectura Fertin Pharma, a subsidiary of Philip Morris International.
Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, has completed the acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group announced in May 2024.
Europa Biosite has announced the acquisition of AMSBIO, a supplier of life science products and services, with expertise in the areas of biospecimens, stem cell research, 3D cell culture, glycobiology, and molecular biology.
Cencora bolstered the support it can offer to pharmaceutical companies through the addition of Public Health Expertise (PHE), a France-based life sciences consulting firm that specialises in market access, health economics and outcomes research.
UK-based drug discovery organisation Concept Life Sciences (CLS), backed by mid-market private equity investment firm Limerston Capital, has completed the acquisition of Charnwood Discovery.
ProductLife Group (PLG) announced the acquisition of Callisto, a UK-based consultancy specialising in Regulatory Affairs (RA), Pharmacovigilance (PV) and GMDP services within multiple regulated sectors.
ProductLife Group announced the acquisition of Halloran Consulting Group, uniting both companies under a commitment to provide safe and effective healthcare solutions across the globe.
This acquisition will significantly enhance Ardena’s capabilities in downstream late-stage and small-scale commercial manufacturing of oral drug products.
Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, announced the acquisition of Alderley Analytical Ltd, based near Manchester, UK.
